Cannabidiol ameliorates the anxiogenic and compulsive-like behaviors induced by chronic consumption of a high-carbohydrate diet in male mice

Metab Brain Dis. 2022 Dec;37(8):2711-2718. doi: 10.1007/s11011-022-01071-9. Epub 2022 Aug 30.

Abstract

The excessive consumption of ultra-processed foods and the development of obesity has been associated with several comorbidities, including psychiatric disorders. Excess fat tissue promotes a low-intensity inflammatory state, mainly in the white tissue, which is essential in developing metabolic alterations and influences brain homeostasis. In this scenario, Cannabidiol (CBD), a compound from Cannabis sativa, has presented anxiolytic and anti-inflammatory effects in murine models. This study verified whether CBD treatment would ameliorate the compulsive-like and anxiety-like behaviors observed after mice's chronic consumption of a high-refined carbohydrate (HC) diet. BALB/c male mice received a control or HC diet for 12 weeks followed by vehicle and CBD (30 mg/Kg, i.p.) administration, and their behavior was evaluated in the Marble Burying test (MB) and Novel Suppressing Feeding test (NSF). The sub-chronic, but not acute, treatment with CBD attenuated the compulsive-like and anxiogenic-like behavior induced by the HC diet. Our data reinforced the harmful effects of the HC diet's chronic consumption on compulsive and anxious behaviors and the potential of CBD as a drug treatment for psychiatric disorders associated with obesity.

Keywords: Anxiety; Cannabidiol; High-carbohydrate diet; Obesity; Obsessive-compulsive disorder.

MeSH terms

  • Animals
  • Cannabidiol* / pharmacology
  • Cannabidiol* / therapeutic use
  • Carbohydrates
  • Compulsive Behavior / chemically induced
  • Compulsive Behavior / drug therapy
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Obesity / chemically induced
  • Obesity / drug therapy

Substances

  • Cannabidiol
  • Carbohydrates